breast cancer - triple negative | |
mBC - TNBC - L1 - all population | |
atezolizumab based treatment | |
atezolizumab plus nab-paclitaxel | IMpassion-130 ... |
atezolizumab plus paclitaxel | IMpassion-131 ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -